Maximizing The Potential Of Rapid Diagnostics To Fight Antimicrobial Resistance

Decorative image of the AMR Learning Lounge

Maximizing The Potential Of Rapid Diagnostics To Fight Antimicrobial Resistance

SUMMARY

Two infectious disease experts call upon everyone to take immediate action to fight antimicrobial resistance (AMR). Christine Ginocchio, PhD draws from her experience with the IDSA and Presidential Advisory Council (PACCARB) to demonstrate the importance of rapid diagnostics to fight against AMR in today’s interconnected world. Pharmacist Tristan Timbrook adds his perspective by describing strategies for how antimicrobial stewardship programs (ASP) can attain and measure success.

FEATURED EXPERTS

Christine Ginocchio, PhD, MT, (RET)

Tristan Timbrook, PharmD, BCPS, Director of Health Economics and Outcomes Research, Global Medical Affairs, bioMérieux

GET STARTED

Read the article at IDStewardship.

Take me there now!

Estimated reading time: 3 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll

Global solutions

VITEK^® 2

VITEK^® 2, the leading automated system for routine antimicrobial susceptibility testing, provides efficient workflow, faster AST results. Its fully-integrated ID & AST approach ensures superior performance to rapidly and confidently guide therapy.

Learn More

US Solutions

VITEK^® 2

VITEK® 2, the leading automated system for routine antimicrobial susceptibility testing, provides efficient workflow, faster AST results. Its fully-integrated ID & AST approach ensures superior performance to rapidly and confidently guide therapy.

Learn More

PUBLISHED BY

IDStewardship
November 30, 2021